socalTechnews
 
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Tuesday, March 18, 2008

    MabVax Therapeutics Raises $8M For Cancer Treatment
    San Diego-based MabVax Therapeutics has recently raised $8M in a Series A funding round, from GBP Capital. The firm is focused on development and commercialization of immunotherapies for the treatment of cancer. According to MabVax, the firm's technology is based on work on monovalent cancer vaccines at the Memorial Sloan-Kettering Cancer Center, which has licensed the technology to MabVax.
    posted on Tuesday, March 18, 2008 (Link to more information)

    Related companies:
    Mabvax Therapeutics

    Related stories:
    > Ascenta Therapeutics Raises $50M
    > Biogen Idec Buys Conforma Therapeutics
    > TargeGen Raises $30M B
    > Trius Therapeutics Finds $20M
    > Ocera Therapeutics Finds $14.5M

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, May 9, 2008
    Thursday, May 8, 2008
    Wednesday, May 7, 2008
    Tuesday, May 6, 2008
    Monday, May 5, 2008